SecBot SecBot
Insider Cluster (1 insider) ·Filed Mar 19, 2026

RVMD

Revolution Medicines, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed7mo ago
Insider cluster: 2 insiders, $281K total
Actionable Insight • Neutral

The activity is consistent with routine option exercise and minimal selling; not a signal of distress or strong conviction. Monitor for additional selling in coming days.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$95.78
T+0 close · Mar 19, 2026 · via day close
Latest settled
+63.48%
T+60 · $156.58
Vs SPY
+47.79%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 20 $95.78entry
  2. T+1 · 8mo ago +0.89%α −0.16% · $96.63
  3. T+5 · 8mo ago −3.41%α −1.18% · $92.51
  4. T+20 · 7mo ago +52.67%α +43.40% · $146.23
  5. T+60 · 5mo ago +63.48%α +47.79% · $156.58
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Anthony Mancini, an insider at Revolution Medicines, exercised options for 74,900 shares and sold 1,800 shares on the open market for $167,801. The majority of the transaction value comes from non-cash derivative exercises, with only a small portion representing actual open-market selling.

Key Financial Metrics

Direction
selling
Total Value
$167.8K
Insiders
1

Key Facts

  • Anthony Mancini exercised options for 74,900 shares in two tranches of 37,450 shares each, one at $0 and one at $33.62 per share, resulting in a total cost of $1,259,069.
  • Mancini sold 1,800 shares on the open market for $167,801 at an average price of $93.223.
  • The total open-market sale represents approximately 0.0009% of Revolution Medicines' $18.7B market cap, well below the 0.1% threshold for materiality.

Financial Impact

$167,801 in open-market sales and $1.26M in derivative exercises (non-cash)

insider ownershippotential dilution

Risk Factors

  • Potential for minor dilution from newly exercised shares, though not material given company size.
  • Perception risk if more insiders follow with similar transactions.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (3 trades, 7d window)cluster-RVMD-1774569874022

US Market Status

Market Closed · Opens Wed (9h 56m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 26, 2026